Evive About Us

Evive Biotech, a subsidiary of Yifan Pharmaceutical, is a global biopharmaceutical company devoted to developing a portfolio of novel biological therapies for patients worldwide. We leverage our proprietary technology platforms to advance a series of innovative drug candidates for oncology, inflammatory and metabolic diseases. Founded in 2004, we currently have operations in the US, EU, Singapore, and China. As one of the top biopharmaceutical companies to develop innovative therapies from China for the world, Evive adopts a holistic approach for drug development, combining exceptional preclinical and clinical research capabilities with our world-class in-house manufacture and regulatory expertise as well as extensive global drug development experience. Through partnerships with industry, physicians, and regulatory authorities, we strive to bring revolutionary remedies to the global markets quickly and efficiently to address unmet medical needs, making a real and lasting difference for patients and their families worldwide.